Picture of TOWA PHARMACEUTICAL logo

4553 — TOWA PHARMACEUTICAL News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Towa Pharmaceutical -2020/21 parent results

May 14 (Reuters)- 
          Towa Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to     NEXT     
                Mar 31, 2021    Mar 31, 2020   Mar 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            115.35          107.65                                
                 (+7.1 pct)      (+5.1 pct)                              
  Operating         19.94           16.74                                
                 (+19.2 pct)     (+5.9 pct)                              
  Recurring         18.63           21.70                                
                 (-14.1 pct)     (+14.4 pct)                             
  Net               13.65           15.25                                
                 (-10.5 pct)     (+12.1 pct)                             
  EPS            277.39 yen      309.99 yen                              
  EPS Diluted    265.95 yen      286.73 yen                              
  Ann Div         44.00 yen       44.00 yen      51.00 yen               
  -Q2 Div         22.00 yen       22.00 yen      27.00 yen               
  -Q4 Div         22.00 yen       22.00 yen      24.00 yen               
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T

Recent news on TOWA PHARMACEUTICAL

See all news